You loved this once. Now nothing brings you joy. Here's the biological reason.

Serotonin is the neurotransmitter most directly linked to pleasure and well-being. Your brain doesn’t make an unlimited supply of it. Instead, it releases serotonin into the synapse (the space between two neurons), and then a transporter protein called the serotonin reuptake transporter (coded by SLC6A4) pulls it back into the nerve cell to be used again. The whole system is built around recycling.

The SLC6A4 gene exists in two main variants: long and short. If you carry the short variant, your serotonin transporter is less efficient at pulling serotonin back from the synapse. Research shows that roughly 40% of the population carries at least one short allele, and the effect is measurable: less serotonin recycling means less serotonin available for the next firing cycle. You feel it as a baseline flatness, a difficulty accessing joy even when you’re doing things you should enjoy.

With the SLC6A4 short variant, your brain has to work harder just to maintain normal serotonin levels in your reward pathways. Stress depletes it faster. Stimulation that would normally trigger pleasure (social connection, accomplishment, anticipation) produces a muted signal. You’re not depressed in the traditional sense yet. You’re just running on a reduced serotonin reserve, and anything that drains it (poor sleep, conflict, even dieting) pushes you into anhedonia.

Serotonin doesn’t exist in the brain until your body makes it. The enzyme tryptophan hydroxylase 2 (TPH2) catalyzes the first and rate-limiting step: converting the amino acid tryptophan into 5-hydroxytryptophan, which is then converted into serotonin. If TPH2 is underactive, you can’t make serotonin efficiently, no matter how much tryptophan you eat.

Variants in TPH2 are common, affecting roughly 20% of the population, and they reduce the enzyme’s activity. The effect is precise: lower TPH2 activity means lower serotonin synthesis in your brain. This is different from the SLC6A4 problem (which is about recycling). This is about the factory itself running slow. You have a production deficit from the ground up.

When TPH2 is compromised, no amount of willpower or gratitude practice can force your brain to make serotonin it’s biochemically unable to produce. You lack the raw material supply. Anhedonia with TPH2 variants feels like flatness that’s there even on good days, even when things should feel good. You’re not anxious or panicked. You’re just fundamentally disconnected from pleasure.

Dopamine and norepinephrine are the chemicals of motivation, focus, and drive. But your brain doesn’t want them floating around indefinitely. The enzyme catechol-O-methyltransferase (COMT) clears these chemicals from your synapses to prevent overstimulation and burnout. Some people have a slow version of this enzyme.

The COMT Val158Met variant exists in a few forms: fast (Val/Val), medium (Val/Met), and slow (Met/Met). Roughly 25% of people of European ancestry are homozygous slow, and these individuals clear dopamine and norepinephrine much more slowly than others. But here’s the counterintuitive part: slow COMT doesn’t mean you have too much dopamine available. It means dopamine and norepinephrine linger in your synapse, creating overstimulation, anxiety, and emotional rigidity. The longer these chemicals stay active, the more your brain adapts downward (downregulation). Over time, your dopamine receptors become less responsive, and you need more stimulation to feel motivated.

With slow COMT, anhedonia often comes with perfectionism, overthinking, and emotional intensity. You feel trapped in stress loops. Your brain can’t shift gears. And because motivation and dopamine are linked, the inability to access pleasure is paired with an inability to access drive. You don’t want to do things, and you’re not excited about outcomes.

Brain-derived neurotrophic factor (BDNF) is the molecule that allows your brain to form new neural connections, strengthen existing ones, and recover from depression. It’s the biological basis of antidepressant response and resilience. When BDNF is high, your brain is plastic and adaptable. When it’s low, your brain gets stuck in the same patterns.

The BDNF Val66Met variant changes how much BDNF your brain secretes in response to activity and stress. Roughly 30% of people carry the Met allele, and carriers produce significantly less BDNF, especially during physical activity or learning. This means your brain has reduced capacity to rewire itself out of depression. Antidepressants often don’t work as well. Exercise, which is supposed to boost BDNF and lift mood, produces a weaker effect. You feel stuck because your brain literally cannot adapt as quickly as other people’s.

With the BDNF Met variant, anhedonia becomes treatment-resistant. You try an antidepressant and it takes longer to work, if it works at all. You exercise and the mood boost is minimal. You’re not broken, your brain just needs a different strategy to stimulate the neuroplasticity that would normally restore pleasure capacity.

Cortisol is your body’s primary stress hormone. When you encounter a threat, your adrenal glands release cortisol, your heart rate goes up, your focus sharpens, and you handle the threat. Then your body should shut off the cortisol response and return to baseline. But that shutdown depends on a protein called FKBP5, which helps your glucocorticoid receptors recognize cortisol and tell your body to stop producing more.

The FKBP5 rs1360780 variant impairs glucocorticoid receptor function. People carrying this variant, roughly 30% of the population, have a harder time shutting off their cortisol response after stress. Their cortisol stays elevated longer, and they take longer to recover emotionally. The stress doesn’t release. It compounds. And chronic cortisol elevation is a direct driver of anhedonia. High cortisol suppresses dopamine and serotonin production, it shrinks the hippocampus (the memory and learning center), and it predicts depression.

With the FKBP5 variant, anhedonia often comes with a sense of being trapped in stress, unable to downshift even when the stressor is gone. You replay conversations. You stay in alert mode. Your nervous system won’t let you relax. And because pleasure and relaxation are linked, anhedonia becomes a chronic state.

Dopamine, serotonin, and norepinephrine need to be cleared from your synapses eventually. The enzyme monoamine oxidase A (MAOA) breaks them down. Some people have a low-activity version of this enzyme, and the effects are complex. Low MAOA means these neurotransmitters persist in your synapses longer, which sounds good on the surface but creates an unstable neurochemistry.

Males with the MAOA-L (low-activity) variant, roughly 30-40% of men, have reduced ability to degrade these neurotransmitters. The result is neurotransmitter levels that fluctuate wildly. One moment you feel energized and socially connected (high dopamine). The next, you crash into fatigue and anhedonia (dopamine clears too fast once the enzyme catches up). These swings are exhausting. Your brain never settles into a stable pleasure baseline.

With low MAOA, anhedonia often alternates with periods of normal or elevated mood. You’re inconsistent, unpredictable to yourself. And because your neurotransmitters are volatile, standard antidepressants can overshoot and make you feel agitated or numb. You need stability, not more dopamine chasing around your brain.